TEAM HEALTH HOLDINGS 8-K 2013
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported): July 2, 2013
Team Health Holdings, Inc.
(Exact name of registrant as specified in its charter)
Registrant’s telephone number, including area code: (865) 693-1000
Former name or former address, if changed since last report
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On July 2, 2013 and July 8, 2013, Steven B. Epstein and Earl P. Holland, respectively, gave notice to the board of directors of Team Health Holdings, Inc. (the “Company”) of their resignation from the Company’s board of directors, in each case, effective on the date the notice was given. Each of Mr. Epstein and Mr. Holland have resigned to pursue other opportunities and not as a result of any disagreement with the Company on any matter relating to its operations, policies or practices.
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
TEAM HEALTH HOLDINGS, INC.
Date: July 9, 2013 By: /s/ David P. Jones
Name: David P. Jones
Title: Executive Vice President and Chief Financial Officer